By Hannah Green The Cambridge company behind the technology that enabled the first-ever pig-to-human kidney transplant earlier this year has raised a mega-round of funding. The biotech eGenesis said on Wednesday that it has closed a $191 million Series D financing led by Lux Capital. Existing investors including Arch Ventures and Leaps by Bayer, as well new investors, also […]
The Biosecure Act could ban Chinese biotechs and hurt Mass. drug developers. But some see an opportunity for local R&D.By Hannah Green Driven by concerns over national security, the federal government is weighing a crackdown on Chinese biotechnology suppliers that would have far-reaching effects in the life sciences industry. The legislation, known as the Biosecure Act, would prevent biotech […]
By Hannah Green Massachusetts Biomedical Initiatives (MBI) is calling on state officials to designate Central Massachusetts as a “Biomanufacturing Hub” and help the region to compete against those in other states. The nonprofit released a regional biomanufacturing strategy on Tuesday. MBI wants to see the state get involved in such areas as building regional talent and incentivizing large-scale […]
